Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Cyclosporine · Cequa, Neoral

Small molecule · Inhibitor of calcineurin · developed by Novartis

Approved FDA, Jul 1995
3 Registered trials

What is Cyclosporine?

Cyclosporine is a calcineurin inhibitor immunosuppressant that acts on T-lymphocytes, particularly T-helper cells, reducing lymphokine production and release. It is used systemically to prevent organ rejection in transplantation and to treat rheumatoid arthritis and psoriasis, and topically in the eye for keratoconjunctivitis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Cequa, Neoral, Sandimmune, Verkazia, NSC-290193, Ciclosporin, Cyclosporins
Drug type
Small molecule
Targets
calcineurin
Mechanism
Inhibitor of calcineurin
Pathways
calcineurin inhibition, lymphokine production and release
Therapy area
Dermatology
Developer
Novartis
In trials of
AKBA, AUPH
FDA status
Approved as Cequa, Neoral, Sandimmune (July 14, 1995), NDA050715 · FDA label
UNII
83HN0GTJ6D

✅ FDA-approved uses

From the indications section of the FDA label (version of Aug 10, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00408187 Phase 3 Psoriasis Completed AUPH
NCT03597139 Phase 2 Dry Eye Completed AUPH
NCT03801746 Phase 1 Drug Interaction Potentiation Completed AKBA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Drug Interaction PotentiationPsoriasis

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.